These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 35659482)
21. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series]. Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011 [TBL] [Abstract][Full Text] [Related]
22. Management of residual disease after chemotherapy in germ cell tumors. King J; Adra N; Einhorn LH Curr Opin Oncol; 2020 May; 32(3):250-255. PubMed ID: 32168037 [TBL] [Abstract][Full Text] [Related]
26. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478 [TBL] [Abstract][Full Text] [Related]
27. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206. Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH Ann Oncol; 2018 Jan; 29(1):209-214. PubMed ID: 29045540 [TBL] [Abstract][Full Text] [Related]
28. Specialist management of testicular cancer: Report of the last 10 years at a Portuguese tertiary referral academic centre. Marques-Pinto A; Gomes AI; Febra J; Rosendo E; Castanheira de Oliveira M; Fraga A; La Fuente de Carvalho J; Louro N Arch Ital Urol Androl; 2021 Jun; 93(2):153-157. PubMed ID: 34286547 [TBL] [Abstract][Full Text] [Related]
29. Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy. Caso R; Jones GD; Tan KS; Bosl GJ; Funt SA; Sheinfeld J; Reuter VE; Amar D; Fischer G; Molena D; Rocco G; Bains MS; Feldman DR; Jones DR Ann Thorac Surg; 2021 Apr; 111(4):1141-1149. PubMed ID: 32882201 [TBL] [Abstract][Full Text] [Related]
30. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study. Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044 [TBL] [Abstract][Full Text] [Related]
31. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases. Balzer BL; Ulbright TM Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328 [TBL] [Abstract][Full Text] [Related]
32. Surgical management of complex residual masses following systemic chemotherapy for metastatic testicular germ cell tumours. Heidenreich A; Haidl F; Paffenholz P; Pape C; Neumann U; Pfister D Ann Oncol; 2017 Feb; 28(2):362-367. PubMed ID: 27831507 [TBL] [Abstract][Full Text] [Related]
33. Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience. Miller MI; Feifer A; Feldman DR; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Sheinfeld J Urology; 2019 Feb; 124():174-178. PubMed ID: 30296502 [TBL] [Abstract][Full Text] [Related]
34. Management of residual non-retroperitoneal disease following chemotherapy for germ cell tumor. Sadeghi N; Badalato GM; Kates M; McKiernan JM Urol Oncol; 2011; 29(6):837-41. PubMed ID: 21489835 [TBL] [Abstract][Full Text] [Related]